EUVIMEDEUVIMED entdecken
Querschnittstudie

Perceptions and Preferences of Indian Clinicians Towards Metoprolol–Am lodipine Fixed-Dose Combination Therapy in Hypertension Management: A Cross-Sectional Survey-Based Study

Roopa Ravi Babu, Sreedhara CG, Niranjan K, Aashish A, Sel Varathinasamy CS, Anurag Srivastav, Zaheer A Virani, Ranabrata Sen, Ashish Singhal, Manoop Mittal, Manjula S, Krishna Kumar M

Academia Journal of Medicine · 28.03.2026 · 9 (1) · 113-123

DOI: 10.48165/ajm.2026.9.01.25 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Academia Journal of Medicine, online erschienen am 28.03.2026. Verfasst von Roopa Ravi Babu und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background:Hypertension remains a leading contributor to cardiovascular morbidity and mortality in India. Combination therapy using fixed-dose formulations like Metoprolol (a β-blocker) and Amlodipine (a calcium channel blocker) has gained attention for improved compliance and synergistic efficacy. However, clinician perspectives on such combinations remain underreported in Indian settings. Objective:To assess the perceptions, prescribing preferences, and clinical rationale of Indian medical professionals regarding the use of Metoprolol–Amlodipine fixed-dose combination (FDC) therapy in the management of hypertension.Methods:A descriptive, cross-sectional survey was conducted among 112 practicing clinicians using a structured questionnaire. The tool captured demographic details, prescribing patterns, therapeutic rationale, patient age-related choices, and perceived benefits or limitations of the Metoprolol–Amlodipine FDC.Results:The majority of respondents (78.6%) preferred the Metoprolol–Amlodipine combination over other antihypertensive FDCs, particularly in younger patients and those with coexisting anxiety or high sympathetic tone. Perceived advantages included effective BP control (86%), improved adherence (72%), and symptom relief. Logistic regression revealed significant associations between clinician age group, years of experience, and preference for the combination (p < 0.05).Conclusion:Indian clinicians show a strong preference for Metoprolol–Amlodipine FDC therapy, attributing it to enhanced therapeutic efficacy, tolerability, and patient compliance. These findings support the growing clinical utility of β-blocker–CCB combinations in routine hypertension management and underscore the need for updated guidelines reflecting real-world practices.

Zitieren

APA

Babu, R. R., CG, S., K, N., A, A., CS, S. V., Srivastav, A., Virani, Z. A., Sen, R., Singhal, A., Mittal, M., S, M., & M, K. K. (2026). Perceptions and Preferences of Indian Clinicians Towards Metoprolol–Am lodipine Fixed-Dose Combination Therapy in Hypertension Management: A Cross-Sectional Survey-Based Study. Academia Journal of Medicine, 9(1), 113-123. https://doi.org/10.48165/ajm.2026.9.01.25

Vancouver

Babu RR, CG S, K N, A A, CS SV, Srivastav A, et al. Perceptions and Preferences of Indian Clinicians Towards Metoprolol–Am lodipine Fixed-Dose Combination Therapy in Hypertension Management: A Cross-Sectional Survey-Based Study. Academia Journal of Medicine. 2026;9(1):113-123. doi:10.48165/ajm.2026.9.01.25

BibTeX
@article{Babu2026,
  author = {Babu, Roopa Ravi and CG, Sreedhara and K, Niranjan and A, Aashish and CS, Sel Varathinasamy and Srivastav, Anurag and Virani, Zaheer A and Sen, Ranabrata and Singhal, Ashish and Mittal, Manoop and S, Manjula and M, Krishna Kumar},
  title = {Perceptions and Preferences of Indian Clinicians Towards Metoprolol–Am lodipine Fixed-Dose Combination Therapy in Hypertension Management: A Cross-Sectional Survey-Based Study},
  journal = {Academia Journal of Medicine},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {113--123},
  doi = {10.48165/ajm.2026.9.01.25}
}
Kostenlos starten →